Literature DB >> 2549912

Hepatic resection in 120 patients with hepatocellular carcinoma.

M F Chen1, T L Hwang, L B Jeng, Y Y Jan, C S Wang, F F Chou.   

Abstract

During the 11-year period from 1977 through 1987, hepatic resections were carried out in 120 patients with hepatocellular carcinoma (HCC). Twenty-five had HCCs smaller than 5 cm in diameter. There were 97 male and 23 female patients, with an average age of 51.5 years. Among them, 45.8% had liver cirrhosis and 80.8% were positive for hepatitis B surface antigen. Fourteen with ruptured HCCs underwent hepatic resection to control the intra-abdominal hemorrhage. Operative mortality within one month after surgery was 4.1%. The postoperative course was complicated by pleural effusion in 5.8%, subphrenic abscess in 2.5%, postoperative bleeding in 1.6%, hepatic failure in 1.6%, and bile leakage in 0.8% of the patients. The overall five-year survival rate in this series was 25.9%, while survival for the last five years was better (42.3% vs 11.9% for patients treated between 1977 and 1982). The cumulative survival rate had no relation to tumor rupture or liver cirrhosis. The group of patients with smaller tumors (diameter, less than 5 cm) or without vascular invasion by tumor had better survival.

Entities:  

Mesh:

Year:  1989        PMID: 2549912     DOI: 10.1001/archsurg.1989.01410090031006

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  22 in total

1.  Hepatic resection for small hepatocellular carcinoma: the Queen Mary Hospital experience.

Authors:  E C Lai; I O Ng; K T You; S T Fan; F P Mok; E S Tan; J Wong
Journal:  World J Surg       Date:  1991 Sep-Oct       Impact factor: 3.352

2.  Role of computed tomographic arterial portography and intraoperative ultrasound in the evaluation of patients for resectability of hepatic lesions.

Authors:  R C Karl; J Choi; T J Yeatman; R A Clark
Journal:  J Gastrointest Surg       Date:  1997 Mar-Apr       Impact factor: 3.452

Review 3.  Therapeutic modalities and prognostic factors for primary and secondary liver tumors.

Authors:  T Lehnert; G Otto; C Herfarth
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

4.  Occurrence of intraperitoneal septic complications after hepatic resections between 1985 and 1990.

Authors:  T Matsumata; K Yanaga; M Shimada; K Shirabe; A Taketomi; K Sugimachi
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

5.  Hepatic resection for hepatocellular carcinoma with obstructive jaundice due to biliary tumor thrombi.

Authors:  Chun-Nan Yeh; Yi-Yin Jan; Wei-Chen Lee; Miin-Fu Chen
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

6.  Hepatocellular carcinoma complicated with coexisting hepatolithiasis: pitfalls in diagnosis and management.

Authors:  T S Yeh; T C Chen; L L Hsieh; Y Y Jan; L B Jeng; T L Hwang; M F Chen
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

7.  Inclusion of tumor markers improves the correlation of the Milan criteria with vascular invasion and tumor cell differentiation in patients with hepatocellular carcinoma undergoing liver resection (#JGSU-D-07-00462).

Authors:  Kiyoshi Hasegawa; Hiroshi Imamura; Masayoshi Ijichi; Yutaka Matsuyama; Keiji Sano; Yasuhiko Sugawara; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  J Gastrointest Surg       Date:  2008-01-18       Impact factor: 3.452

Review 8.  Liver transplantation for hepatocellular carcinoma: clinical results and future aspects.

Authors:  R Pichlmayr; A Weimann; G Steinhoff; B Ringe
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

9.  Clinical experience of hepatic hemangioma undergoing hepatic resection.

Authors:  Hsiu-Pei Tsai; Long-Bin Jeng; Wei-Chen Lee; Miin-Fu Chen
Journal:  Dig Dis Sci       Date:  2003-05       Impact factor: 3.199

10.  Hepatic resection versus transplantation for hepatocellular carcinoma.

Authors:  S Iwatsuki; T E Starzl; D G Sheahan; I Yokoyama; A J Demetris; S Todo; A G Tzakis; D H Van Thiel; B Carr; R Selby
Journal:  Ann Surg       Date:  1991-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.